Generalizable biomarkers in Critical Care: Toward precision medicine

Critical Care Medicine

Volumn 45, Issue 6, 2017, Pages 934-939

  Sweeney, Timothy E ^a   Khatri, Purvesh ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ADULT RESPIRATORY DISTRESS SYNDROME; CLINICAL TRIAL (TOPIC); COHORT ANALYSIS; CRITICAL ILLNESS; DIAGNOSTIC ACCURACY; HUMAN; INTENSIVE CARE; METABOLOMICS; PERSONALIZED MEDICINE; PRIORITY JOURNAL; REPRODUCIBILITY; REVIEW; AGE; COMORBIDITY; MEDICAL RESEARCH; PROCEDURES; SENSITIVITY AND SPECIFICITY; SOCIOECONOMICS; SYNDROME;

AGE FACTORS; BIG DATA; BIOMARKERS; BIOMEDICAL RESEARCH; COMORBIDITY; CRITICAL CARE; HUMANS; PRECISION MEDICINE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOCIOECONOMIC FACTORS; SYNDROME;

EID: 85020481549     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000002402     Document Type: Review

References (58)

1. Ioannidis JP: Why most published research findings are false. PLoS Med 2005; 2:e124
2. Goodman SN, Fanelli D, Ioannidis JP: What does research reproducibility mean? Sci Transl Med 2016; 8:341ps12
3. Open Science Collaboration: PSYCHOLOGY. Estimating the reproducibility of psychological science. Science 2015; 349:aac4716
4. Opal SM, Dellinger RP, Vincent JL, et al: The next generation of sepsis clinical trial designs: What is next after the demise of recombinant human activated protein C? Crit Care Med 2014; 42:1714-1721
5. Cohen J, Vincent JL, Adhikari NK, et al: Sepsis: A roadmap for future research. Lancet Infect Dis 2015; 15:581-614
6. Yadav H, Thompson BT, Gajic O: Fifty years of research in ARDS. Is acute respiratory distress syndrome a preventable disease? Am J Respir Crit Care Med 2016 Dec 31. [Epub ahead of print]
7. de Caestecker M, Humphreys BD, Liu KD, et al; ASN AKI Advisory Group: Bridging translation by improving preclinical study design in AKI. J Am Soc Nephrol 2015; 26:2905-2916
8. Marshall JC: Why have clinical trials in sepsis failed? Trends Mol Med 2014; 20:195-203
9. Ioannidis JP, Ntzani EE, Trikalinos TA, et al: Replication validity of genetic association studies. Nat Genet 2001; 29:306-309
10. Venet D, Dumont JE, Detours V: Most random gene expression signatures are significantly associated with breast cancer outcome. PLoS Comput Biol 2011; 7:e1002240
11. Ioannidis JP: Biomarker failures. Clin Chem 2013; 59:202-204
12. Bone RC, Balk RA, Cerra FB, et al: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101:1644-1655
13. Levy MM, Fink MP, Marshall JC, et al: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31:1250-1256
14. Singer M, Deutschman CS, Seymour CW, et al: The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315:801-810
15. Sweeney TE, Haynes WA, Vallania F, et al: Methods to increase reproducibility in differential gene expression via meta-analysis. Nucleic Acids Res 2017; 45:e1
16. Khatri P, Roedder S, Kimura N, et al: A common rejection module (CRM) for acute rejection across multiple organs identifies novel therapeutics for organ transplantation. J Exp Med 2013; 210:2205-2221
17. Chen R, Khatri P, Mazur PK, et al: A meta-analysis of lung cancer gene expression identifies PTK7 as a survival gene in lung adenocarcinoma. Cancer Res 2014; 74:2892-2902
18. Li MD, Burns TC, Morgan AA, et al: Integrated multi-cohort transcriptional meta-analysis of neurodegenerative diseases. Acta Neuropathol Commun 2014; 2:93
19. Mazur PK, Reynoird N, Khatri P, et al: SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer. Nature 2014; 510:283-287
20. Sweeney TE, Shidham A, Wong HR, et al: A comprehensive timecourse-based multicohort analysis of sepsis and sterile inflammation reveals a robust diagnostic gene set. Sci Transl Med 2015; 7:287ra71
21. Sweeney TE, Khatri P: Benchmarking sepsis gene expression diagnostics using public data. Crit Care Med 2017; 45:1-10
22. Sweeney TE, Braviak L, Tato CM, et al: Genome-wide expression for diagnosis of pulmonary tuberculosis: A multicohort analysis. Lancet Respir Med 2016; 4:213-224
23. Sweeney TE, Perumal TM, Henao R, et al: Mortality prediction in sepsis via gene expression analysis: A community approach. bioRxiv 2016 Dec 19. [Epub ahead of print]
24. Sweeney TE, Wong HR, Khatri P: Robust classification of bacterial and viral infections via integrated host gene expression diagnostics. Sci Transl Med 2016; 8:346ra91
25. Bauchner H, Golub RM, Fontanarosa PB: Data sharing: An ethical and scientific imperative. JAMA 2016; 315:1237-1239
26. Mao H, Wang H, Wang B, et al: Systemic metabolic changes of traumatic critically ill patients revealed by an NMR-based metabonomic approach. J Proteome Res 2009; 8:5423-5430
27. 1H-nuclear magnetic resonance quantitative metabolomics and computational analysis. Am J Physiol Lung Cell Mol Physiol 2011; 300:L4-L11
28. Schmerler D, Neugebauer S, Ludewig K, et al: Targeted metabolomics for discrimination of systemic inflammatory disorders in critically ill patients. J Lipid Res 2012; 53:1369-1375
29. Antti H, Fahlgren A, Näsström E, et al: Metabolic profiling for detection of Staphylococcus aureus infection and antibiotic resistance. PLoS One 2013; 8:e56971
30. Blaise BJ, Gouel-Chéron A, Floccard B, et al: Metabolic phenotyping of traumatized patients reveals a susceptibility to sepsis. Anal Chem 2013; 85:10850-10855
31. Mickiewicz B, Vogel HJ, Wong HR, et al: Metabolomics as a novel approach for early diagnosis of pediatric septic shock and its mortality. Am J Respir Crit Care Med 2013; 187:967-976
32. Langley RJ, Tsalik EL, van Velkinburgh JC, et al: An integrated clinicometabolomic model improves prediction of death in sepsis. Sci Transl Med 2013; 5:195ra95
33. Kamisoglu K, Sleight KE, Calvano SE, et al: Temporal metabolic profiling of plasma during endotoxemia in humans. Shock 2013; 40:519-526
34. Seymour CW, Yende S, Scott MJ, et al: Metabolomics in pneumonia and sepsis: An analysis of the GenIMS cohort study. Intensive Care Med 2013; 39:1423-1434
35. Bos LD, Weda H, Wang Y, et al: Exhaled breath metabolomics as a noninvasive diagnostic tool for acute respiratory distress syndrome. Eur Respir J 2014; 44:188-197
36. 1HNMR based urine metabolomic profiles of IUGR, LGA and AGA newborns on the first day of life. J Matern Fetal Neonatal Med 2014; 27(Suppl 2):13-19
37. Evans CR, Karnovsky A, Kovach MA, et al: Untargeted LC-MS metabolomics of bronchoalveolar lavage fluid differentiates acute respiratory distress syndrome from health. J Proteome Res 2014; 13:640-649
38. Fanos V, Caboni P, Corsello G, et al: Urinary (1)H-NMR and GC-MS metabolomics predicts early and late onset neonatal sepsis. Early Hum Dev 2014; 90(Suppl 1):S78-S83
39. Mickiewicz B, Duggan GE, Winston BW, et al; Alberta Sepsis Network: Metabolic profiling of serum samples by 1H nuclear magnetic resonance spectroscopy as a potential diagnostic approach for septic shock. Crit Care Med 2014; 42:1140-1149
40. Rogers AJ, McGeachie M, Baron RM, et al: Metabolomic derangements are associated with mortality in critically ill adult patients. PLoS One 2014; 9:e87538
41. Su L, Huang Y, Zhu Y, et al: Discrimination of sepsis stage metabolic profiles with an LC/MS-MS-based metabolomics approach. BMJ Open Respir Res 2014; 1:e000056
42. Puskarich MA, Finkel MA, Karnovsky A, et al: Pharmacometabolomics of l-carnitine treatment response phenotypes in patients with septic shock. Ann Am Thorac Soc 2015; 12:46-56
43. Garcia-Simon M, Morales JM, Modesto-Alapont V, et al: Prognosis biomarkers of severe sepsis and septic shock by 1H NMR urine metabolomics in the intensive care unit. PLoS One 2015; 10:e0140993
44. Mickiewicz B, Thompson GC, Blackwood J, et al; Alberta Sepsis Network: Development of metabolic and inflammatory mediator biomarker phenotyping for early diagnosis and triage of pediatric sepsis. Crit Care 2015; 19:320
45. Su L, Li H, Xie A, et al: Dynamic changes in amino acid concentration profiles in patients with sepsis. PLoS One 2015; 10:e0121933
46. Richter ME, Neugebauer S, Engelmann F, et al: Biomarker candidates for the detection of an infectious etiology of febrile neutropenia. Infection 2016; 44:175-186
47. Kauppi AM, Edin A, Ziegler I, et al: Metabolites in blood for prediction of bacteremic sepsis in the emergency room. PLoS One 2016; 11:e0147670
48. Ferrario M, Cambiaghi A, Brunelli L, et al: Mortality prediction in patients with severe septic shock: A pilot study using a target metabolomics approach. Sci Rep 2016; 6:20391
49. Neugebauer S, Giamarellos-Bourboulis EJ, Pelekanou A, et al: Metabolite profiles in sepsis: Developing prognostic tools based on the type of infection. Crit Care Med 2016; 44:1649-1662
50. Liu Z, Yin P, Amathieu R, et al: Application of LC-MS-based metabolomics method in differentiating septic survivors from non-survivors. Anal Bioanal Chem 2016; 408:7641-7649
51. Stewart CJ, Nelson A, Treumann A, et al: Metabolomic and proteomic analysis of serum from preterm infants with necrotising entercolitis and late-onset sepsis. Pediatr Res 2016; 79:425-431
52. Mogensen KM, Lasky-Su J, Rogers AJ, et al: Metabolites associated with malnutrition in the intensive care unit are also associated with 28-day mortality. JPEN J Parenter Enteral Nutr 2017; 41:188-197
53. Lau SK, Lee KC, Lo GC, et al: Metabolomic profiling of plasma from melioidosis patients using UHPLC-QTOF MS reveals novel biomarkers for diagnosis. Int J Mol Sci 2016; 17:307
54. Mills KH: TLR-dependent T cell activation in autoimmunity. Nat Rev Immunol 2011; 11:807-822
55. Collins GS, Reitsma JB, Altman DG, et al: Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): The TRIPOD statement. Ann Intern Med 2015; 162:55-63
56. Bossuyt PM, Reitsma JB, Bruns DE, et al; STARD Group: STARD 2015: An updated list of essential items for reporting diagnostic accuracy studies. BMJ 2015; 351:h5527
57. Assicot M, Gendrel D, Carsin H, et al: High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341:515-518
58. Wang X, Li ZY, Zeng L, et al: Neutrophil CD64 expression as a diagnostic marker for sepsis in adult patients: A meta-analysis. Crit Care 2015; 19:245